Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a single injection of Dysport with a new
protocol at forearm is effective in the management of chronic lateral epicondylitis.
Phase:
Phase 3
Details
Lead Sponsor:
Tehran University of Medical Sciences
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA